Cargando…

The data‐collection on adverse effects of anti‐HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV

OBJECTIVES: Little is known about the external validity of the Data‐collection on Adverse Effects of Anti‐HIV Drugs (D:A:D) model for predicting cardiovascular disease (CVD) risk among people living with HIV (PLWH). We aimed to evaluate the performance of the updated D:A:D model for 5‐year CVD risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anikpo, Ifedioranma, Agovi, Afiba Manza‐A., Cvitanovich, Matthew J., Lonergan, Frank, Johnson, Marc, Ojha, Rohit P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290794/ https://www.ncbi.nlm.nih.gov/pubmed/34414654 http://dx.doi.org/10.1111/hiv.13147

Ejemplares similares

Knowledge needs for implementing HIV pre-exposure prophylaxis among primary care providers in a safety-net health system
por: Agovi, Afiba Manza-A., et al.
Publicado: (2020)

Effect of 2018 American College of Cardiology/American Heart Association Guideline Change on Statin Prescription for People Living with HIV
por: Pan, Meng, et al.
Publicado: (2023)

Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study
por: Petoumenos, Kathy, et al.
Publicado: (2012)

Validation of the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) chronic kidney disease risk score in HIV‐infected patients in the USA
por: Mills, AM, et al.
Publicado: (2020)

Presence of the Metabolic Syndrome Is Not a Better Predictor of Cardiovascular Disease Than the Sum of Its Components in HIV-Infected Individuals: Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) study
por: Worm, Signe W., et al.
Publicado: (2009)

Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study()
por: Hatleberg, Camilla Ingrid, et al.
Publicado: (2019)

Comparison of Risk Category Predictions of Framingham Risk Score (FRS), Atherosclerotic Cardiovascular Disease Risk Score (ASCVD), Systematic Coronary Risk Evaluation (SCORE) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) in HIV Infected Patients
por: Korten, Volkan, et al.
Publicado: (2017)

Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study
por: Hatleberg, Camilla I, et al.
Publicado: (2018)

Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study
por: Hatleberg, Camilla Ingrid, et al.
Publicado: (2014)

Cardiotoxicity among socioeconomically marginalized breast cancer patients
por: Lu, Yan, et al.
Publicado: (2022)

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study
por: Kamara, David A, et al.
Publicado: (2014)

Rates and Correlates of HIV Incidence in Namibia’s Zambezi Region From 2014 to 2016: Sentinel, Community-Based Cohort Study
por: Maher, Andrew D, et al.
Publicado: (2020)

Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score
por: Hsu, R, et al.
Publicado: (2020)

Cardiovascular risk evaluation of HIV-positive patients in a case-control study: comparison of the D:A:D and Framingham equations
por: Markowicz, Samuel, et al.
Publicado: (2014)

Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
por: Mocroft, Amanda, et al.
Publicado: (2015)

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study
por: Boyd, Mark A., et al.
Publicado: (2017)

925. Adverse Events Due to Inappropriate Prescribing in Older Adults Living with HIV
por: Cinquegrani, Mark, et al.
Publicado: (2020)

Who's Your DadA? d-Alanine Levels Regulate Bacterial Stiffness
por: Odermatt, Pascal D., et al.
Publicado: (2018)

Cardiovascular Risk Assessment: A Comparison of the Framingham, PROCAM, and DAD Equations in HIV-Infected Persons
por: Nery, Max Weyler, et al.
Publicado: (2013)

Subclinical Carotid Atherosclerosis and Reduced DAD Score for Cardiovascular Risk Stratification in HIV-Positive Patients
por: Silva, Achilles Gustavo, et al.
Publicado: (2020)

Adverse events of pancreatic fluid collections
por: Baars, Judith E., et al.
Publicado: (2017)

High risk of adverse birth outcomes among adolescents living with HIV in Botswana compared to adult women living with HIV and adolescents without HIV
por: Jackson-Gibson, Maya, et al.
Publicado: (2022)

Factors associated to modification of first-line antiretroviral therapy due to adverse events in people living with HIV/AIDS
por: Azevedo, Larissa Negromonte, et al.
Publicado: (2019)

Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D study
por: Smith, Colette, et al.
Publicado: (2014)

Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study
por: Kovari, Helen, et al.
Publicado: (2016)

Assessment of the agreement between the Framingham and DAD risk equations for estimating cardiovascular risk in adult Africans living with HIV infection: a cross-sectional study
por: Noumegni, Steve Raoul, et al.
Publicado: (2017)

Factors associated with external HIV-related stigma and psychological distress among people living with HIV in South Africa
por: Ncitakalo, Nolusindiso, et al.
Publicado: (2021)

The suspected unexpected and serious adverse events of antiretroviral drugs used as HIV prophylaxis in HIV uninfected persons
por: Pietraszkiewicz, Ewa, et al.
Publicado: (2014)

Sex differences and adverse events of antiretrovirals in people living with HIV/AIDS: a systematic review and meta-analysis protocol
por: de Oliveira, Jardel Corrêa, et al.
Publicado: (2022)

Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study
por: Worm, Signe W, et al.
Publicado: (2013)

An HIV-infected Patient with No Serious Adverse Events after Overdosing on Raltegravir
por: Hosoda, Tomohiro, et al.
Publicado: (2019)

Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
por: Wu, Songjie, et al.
Publicado: (2021)

Risk of adverse coronavirus disease 2019 outcomes for people living with HIV
por: Mellor, Maya M., et al.
Publicado: (2021)

The Dad's Survival Guide
por: Kelly, B
Publicado: (2002)

Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIV
por: Portilla, Joaquín, et al.
Publicado: (2014)

Patient Reported Central Nervous System Adverse Events of Efavirenz-Based Antiretroviral Therapy in People Living with HIV in Northwest Ethiopia
por: Muche, Esileman Abdela, et al.
Publicado: (2020)

Adverse events after vaccination among HIV-positive persons, 1990–2016
por: Su, John R., et al.
Publicado: (2018)

Virological and Immunological Status of the People Living with HIV/AIDS Undergoing ART Treatment in Nepal
por: Ojha, Chet Raj, et al.
Publicado: (2016)

Simultaneous quantitation of chloroquine and primaquine by UPLC-DAD and comparison with a HPLC-DAD method
por: Miranda, Tiago A, et al.
Publicado: (2015)

Adverse Events of Latent Tuberculosis Treatment With Isoniazid in People Living With HIV: A Case-Control Study in a Resource-Rich Setting
por: Carlos Silveira Machado, António, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l4f4ru31bigq3riul3qptaadjj